Monkeys with Parkinson’s disease benefit from human stem cells
Japanese neurosurgeons report two new strategies to improve outcomes of iPS cell-based therapies for Parkinson’s disease in monkey brains. The findings are a key step for patient recruitment of the first iPS cell-based therapy to treat neurodegenerative diseases. …read more
